InvestorsHub Logo
Followers 154
Posts 2653
Boards Moderated 0
Alias Born 01/29/2004

Re: None

Tuesday, 03/15/2022 12:35:07 PM

Tuesday, March 15, 2022 12:35:07 PM

Post# of 464065
Another Anavex Success. Safety and Efficacy Again.

I just zoomed in and perused today's PDF:
https://79bcf7a1-8b8e-483b-b7cf-f5c5192a6d63.usrfiles.com/ugd/79bcf7_ff6b864593fb4418ab306474dd535d35.pdf

Everything absolutely positive; exactly as I’ve expected and predicted. Once again, the unique, novel, proprietary Anavex science in the treatment of a severe CNS disease is proven safe and effective, in real humans with a real CNS disease. This time, not transgenic mice. Real people, with a real disease, with really positive therapeutic outcomes.

Notice that so far, not a single post from an Anavex naysayer telling how the study data and outcomes were flawed, inaccurate, or poor. Just the usuals with the usual: “Yea, but it took too long. The drug won’t get approved until five years from now, if ever.”

I sent the PDF off to my brother-in-law, who has Parkinson’s disease still in early stages. In a year or two, he’ll be able to stop, perhaps even reverse the progression of his Parkinson’s. His neurologist will be able to prescribe it. Or, even before, he may be able participate in the Phase 3 study. For him, and all with Parkinson’s, I’m delighted.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News